Action 300832 SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shenzhen New Industries Biomedical Engineering Co., Ltd.

Actions

300832

CNE100003T39

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 24/04/2024 		Varia. 5j. Varia. 1 janv.
69,15 CNY +1,35 % Graphique intraday de Shenzhen New Industries Biomedical Engineering Co., Ltd. +10,06 % -11,57 %
12/04 Les bénéfices de Shenzhen New Industries Biomedical Engineering pour 2023 font un bond de 25%. MT
11/04 Shenzhen New Industries Biomedical Engineering Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Five Devices
Shenzhen New Industries Biomedical Engineering's 2023 Profit Jumps 25%
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen New Industries' Profit Jumps 32% in H1
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 08 June 2023
Shenzhen New Industries Biomedical Engineering's Shareholders Plan To Unload Company Stakes
Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-MAY-2023.
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Proposal for 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenzhen Yinghe Brain Science Co., Ltd announced that it has received $14.800000 million in funding from Eli Lilly Investment Consulting Shanghai Co., Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Beijing Enlight Media Co., Ltd., Xi'an Xijiao 1896 Capital Management Co., Ltd., Shenzhen Qianhai BangQin Investment Co., Ltd. and other investors.
ANALYSEN DES TAGES von Dow Jones Newswires (18.01.2023)
Shenzhen New Industries Receives Provincial Registration Certificate for Parathyroid Hormone Kit
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Implements Final Cash Dividend for 2021, Payable on 23 June 2022
Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for 2021
Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution Plan for 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300832
  4. Actualités Shenzhen New Industries Biomedical Engineering Co., Ltd.
  5. Autres langues